22 Biopharma Stocks With Breakout Potential in 2012

Description:

According to Adam Feuerstein, "Drug approval decisions garner big headlines, but savvy and successful biotech investors know that making smart trading decisions ahead of important clinical trial results is the ticket to banking serious coin." Read more here.

>>Also: 6 Stocks to Play if the Market Tanks

>>Also: 3 Hot Stocks for a Sideways Market

Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

Time to Sell These 5 'Toxic' Stocks

11.21.14 | 11:27 AM

BALTIMORE ( Stockpickr) -- Which stocks should I buy? It's the eternal question that most investors spend most of their time wondering. But is it t...

5 Earnings Short-Squeeze Plays

11.20.14 | 09:26 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter